Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
Sector
Healthcare
Region
US
AUM
70.11M
Fund Score
AltShares Merger Arbitrage ETF (ARCA:ARB) Quotes, Forecast and News Summary
AltShares Merger Arbitrage ETF (ARCA: ARB) stock price, news, charts, stock research, profile.
| Open | - |
| High | - |
| 52 Wk High | $28.30 |
| AUM | 70.11M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | - |
| Market Cap | $15.08B |
| Mgmt Fee | 0.75% |
| P/E Ratio | 20.88 |
| Prev. Close | $27.87 |
| Low | - |
| 52 Wk Low | $25.81 |
| Shares Out | 2.61M |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | 9.98K |
| Beta | 0.07 |
| Avg. Expense Ratio | 0.77% |
| P/B Ratio | 2.20 |
Recent News
FAQ
Q
How do I buy AltShares Merger Arbitrage ETF (ARB) stock?
A
You can purchase shares of AltShares Merger Arbitrage ETF (ARCA:ARB) through any online brokerage.
Q
Who are AltShares Merger Arbitrage ETF (ARB) competitors?
A
There are no as such competitors for AltShares Merger Arbitrage ETF.
Q
What is the forecast, or price target, for AltShares Merger Arbitrage ETF (ARB) stock?
A
There is no analysis for AltShares Merger Arbitrage ETF to provide a consensus price target.
Q
What is the current price for AltShares Merger Arbitrage ETF (ARB)?
A
The stock price for AltShares Merger Arbitrage ETF (ARCA: ARB) is $27.8743 last updated November 12, 2024 at 8:00 PM EST.
Q
Does AltShares Merger Arbitrage ETF (ARB) pay a dividend?
A
A quarterly cash dividend of 0.23 per share of Class A Common Stock. The quarterly cash dividend was payable on January 1, 2013 to stockholders of record on December 12, 2013.
Q
When is AltShares Merger Arbitrage ETF (ARCA:ARB) reporting earnings?
A
AltShares Merger Arbitrage ETF does not have any upcoming earnings scheduled.
Q
Is AltShares Merger Arbitrage ETF (ARB) going to split?
A
There is no upcoming split for AltShares Merger Arbitrage ETF.
| Open | - |
| High | - |
| 52 Wk High | $28.30 |
| AUM | 70.11M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | - |
| Market Cap | $15.08B |
| Mgmt Fee | 0.75% |
| P/E Ratio | 20.88 |
| Prev. Close | $27.87 |
| Low | - |
| 52 Wk Low | $25.81 |
| Shares Out | 2.61M |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | 9.98K |
| Beta | 0.07 |
| Avg. Expense Ratio | 0.77% |
| P/B Ratio | 2.20 |
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Market Neutral Strategy |
| Fund Inception | May 7, 2020 |
| Managers | Christopher Plunkett Eric Becker John Orrico |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
The Fund seeks to track the performance of the Underlying Index, which is designed to reflect a global merger arbitrage strategy. The most common approach to merger arbitrage, and the approach the Underlying Index (and by extension the Fund) reflects, is to seek to capture the difference (the Spread) between the price at which the stock of a target company in a publicly announced merger, takeover, tender offer, or leveraged buy-out (the Target) trades after the announcement of the acquisition and the price the acquiring company (the Acquirer) has agreed to pay for the stock of the Target.
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2024 Benzinga | All Rights Reserved